Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Arnon, Shahar"'
Autor:
Limor Adler, Bar Cohen, Shirley Shapiro Ben Daviv, Ori Liran, Daniella Rahamim-Cohen, Afif Nakhleh, Arnon Shahar, Joseph Azuri
Publikováno v:
Israel Journal of Health Policy Research, Vol 13, Iss 1, Pp 1-9 (2024)
Abstract Background The use of opioids has increased dramatically over the past several years in Israel. The aim of this study was to explore the trends of opioid consumption in Israel over a decade (2010–2020) stratified by socioeconomic status (S
Externí odkaz:
https://doaj.org/article/fc2ec35cf7d148849326459b4008aeb5
Autor:
Limor Adler, Shafeek Abu Arar, Ilan Yehoshua, Bar Cohen, Sharon Hermoni Alon, Arnon Shahar, Galia Zacay, Miri Mizrahi Reuveni
Publikováno v:
Tobacco Induced Diseases, Vol 21, Iss May, Pp 1-9 (2023)
Introduction Smoking is the leading preventable cause of death and illness globally. There is conflicting evidence regarding the association between quitting rates and partners’ smoking status. It is thought that spouses influence one another’s h
Externí odkaz:
https://doaj.org/article/a0e1bb00d5e24b6aa08b4db98434dce4
Autor:
Robert Hoffman, Zachi Grossman, Joseph Azuri, Limor Adler, Moran Israel, Ilan Yehoshua, Arnon Shahar, Miri Mizrahi Reuveni
Publikováno v:
BMJ Open, Vol 13, Iss 2 (2023)
Objectives To estimate the prevalence of long COVID symptoms in children with and without a history of SARS-CoV-2 infection and to evaluate factors associated with long COVID.Design A nationwide cross-sectional study.Setting Primary care.Participants
Externí odkaz:
https://doaj.org/article/26ab94dc7efa4a5e934edb1a28eddd4e
Publikováno v:
In International Journal of Medical Informatics September 2021 153
Autor:
Miri Mizrahi Reuveni, Jennifer Kertes, Shirley Shapiro Ben David, Arnon Shahar, Naama Shamir-Stein, Keren Rosen, Ori Liran, Mattan Bar-Yishay, Limor Adler
Publikováno v:
Biomedicines, Vol 11, Iss 3, p 767 (2023)
Background: Risk stratification models have been developed to identify patients that are at a higher risk of COVID-19 infection and severe illness. Objectives To develop and implement a scoring tool to identify COVID-19 patients that are at risk for
Externí odkaz:
https://doaj.org/article/ff71f22cdf2e4c61b19a9f8b855e7030
Autor:
Jennifer Kertes, Shirley Shapiro Ben David, Noya Engel-Zohar, Keren Rosen, Beatriz Hemo, Avner Kantor, Limor Adler, Naama Shamir Stein, Miri Mizrahi Reuveni, Arnon Shahar
Publikováno v:
Clinical Infectious Diseases. 76:e126-e132
Background Intramuscular AZD7442 (tixagevimab–cilgavimab [Evusheld; AstraZeneca]) has been found effective among immunocompromised individuals (ICIs) in reducing SARS-CoV-2 infection and severe disease in ICIs. We evaluated the association between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd39110e6957afc3e43f485e69e2e757
https://doi.org/10.1093/cid/ciac625
https://doi.org/10.1093/cid/ciac625
Autor:
Shirley Shapiro Ben David, Barak Mizrahi, Daniella Rahamim-Cohen, Lia Supino-Rosin, Arnon Shahar, Sharon Hermoni-Alon, Ariela Fremder Sacerdote, Angela Irony, Rachel Lazar, Nir Kalkstein, Yaniv Lustig, Victoria Indenbaum, Daniel Landsberger, Miri Mizrahi-Reuveni, Shirley Shapira
Publikováno v:
Vaccine. 40:4038-4045
As protection from COVID-19 following two doses of the BNT162b2 vaccine showed a time dependent waning, a third (booster) dose was administrated. This study aims to compare the antibody response following the third dose versus the second and to evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaefddb4df15e05e254e989625176716
https://doi.org/10.1016/j.vaccine.2022.05.051
https://doi.org/10.1016/j.vaccine.2022.05.051
Autor:
Michal, Stein, Zachi, Grossman, Tal, Brosh-Nissimov, Bat-Sheva, Gottesman, Arnon, Shahar, Efrat, Wechsler, Eran, Matz, Orna, Cohen, Sharon, Alroy-Preis, Emilia, Anis
Publikováno v:
Acta Paediatrica. 111:834-841
This paper describes the emergency, compassionate use of the COVID-19 vaccination for high-risk adolescents aged 12-15 years prior to approval by the American Food and Drugs Administration in May 2021. The target audience had underlying health condit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7031912a36243186a2cc1c542b0124ba
https://doi.org/10.1111/apa.16226
https://doi.org/10.1111/apa.16226
Autor:
Limor Adler, Moran Israel, Ilan Yehoshua, Joseph Azuri, Robert Hoffman, Arnon Shahar, Miri Mizrahi Reuveni, Zachi Grossman
Publikováno v:
BMJ Open. 13:e064155
ObjectivesTo estimate the prevalence of long COVID symptoms in children with and without a history of SARS-CoV-2 infection and to evaluate factors associated with long COVID.DesignA nationwide cross-sectional study.SettingPrimary care.Participants324
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9226cd49eadce23b97fca5fff2c4e608
https://doi.org/10.1136/bmjopen-2022-064155
https://doi.org/10.1136/bmjopen-2022-064155